In today’s recent session, 0.48 million shares of the Mustang Bio Inc (NASDAQ:MBIO) have been traded, and its beta is 1.77. Most recently the company’s share price was $0.18, and it changed around $0.0 or -1.63% from the last close, which brings the market valuation of the company to $9.37M. MBIO at last check was trading at a discount to its 52-week high of $1.53, offering almost -750.0% off that amount. The share price’s 52-week low was $0.13, which indicates that the recent value has risen by an impressive 27.78% since then. We note from Mustang Bio Inc’s average daily trading volume that its 10-day average is 0.79 million shares, with the 3-month average coming to 1.89 million.
Mustang Bio Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended MBIO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Mustang Bio Inc is expected to report earnings per share of -0.16 for the current quarter.
Mustang Bio Inc (NASDAQ:MBIO) trade information
Instantly MBIO has been showing red trend so far today with a performance of -1.63% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.1900 on recent trading dayincreased the stock’s daily price by 5.26%. The company’s shares are currently down -86.60% year-to-date, but still up 7.81% over the last five days. On the other hand, Mustang Bio Inc (NASDAQ:MBIO) is -4.79% down in the 30-day period. We can see from the shorts that 0.37 million shares have been sold at a short interest cover period of 0.61 day(s).
Mustang Bio Inc (MBIO) estimates and forecasts
Mustang Bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -62.65 percent over the past six months and at a 86.50% annual growth rate that is well above the industry average of 16.70%. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 18.87%.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 7.48% of Mustang Bio Inc shares, and 5.72% of them are in the hands of institutional investors. The stock currently has a share float of 6.19%.
